ANALYSIS OF THE CONTENT OF IMMUNE COMPLEXES IN BLOOD MILK IN PATIENTS WITH MULTIPLE SCLEROSIS WITH PATHOGENETIC AND DISEASE CHARACTERISTIC THERAPY
Keywords:multiple sclerosis; immunoglobulins; antibodies to the main protein of myelin; antibodies to components of secondary-necrotic cells.
In order to determine the activity of multiple sclerosis (MS), in particular for the objective confirmation of exacerbation of the disease, it is proposed to conduct a test for analyzing the antibody to the main myelin protein (OBM) and determining the antibodies to the components of the secondary non-necrotic cells (SNEC).
BiermannMHC, GriffanteG, PodolskaMJ, etal. Sweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation. Lupus. 2016;25:934–942.
Blauth K, Owens GP, Bennett JL. The Ins and Outs of B Cells in Multiple Sclerosis. Front. Immunol. 2015;6.
Breij ECW, Brink BP, Veerhuis R, et al. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008;63:16–25.
Kao D, Lux A, Schaffert A, et al. IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice. Eur. J. Immunol. 2017.
Lin C-W, Tsai M-H, Li S-T, et al. A common glycan structure on immunoglobulin G for enhancement of effector functions. Proc. Natl. Acad. Sci. U. S. A. 2015;112:10611–10616.
Munoz LE, Lauber K, Schiller M, et al. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010/05/01. 2010;6:280–289.
Reusch D, Haberger M, Falck D, et al. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods. MAbs. 2015;7:732–742.
Stümer J, Biermann MHCHC, Knopf J, et al. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy. Clin. Exp. Immunol. 2017;189:372–382.
Sjöwall C, Zapf J, von Löhneysen S, et al. Altered glycosylation ofcomplexed native IgG molecules is associated with disease activity of systemic lupus erythematosus. Lupus. 2015;24:569–581.
Trbojević-Akmačić I, Vilaj M, Lauc G. High-throughput analysis of immunoglobulin G glycosylation. Expert Rev. Proteomics. 2016;13:523–534.